A 70-year-old with HFrEF (EF 30%), NYHA II, is on ACE inhibitor, beta blocker, and MRA. eGFR 65 mL/min/1.73m², K+ 4.8. Next disease-modifying therapy ...

Question

A 70-year-old with HFrEF (EF 30%), NYHA II, is on ACE inhibitor, beta blocker, and MRA. eGFR 65 mL/min/1.73m², K+ 4.8. Next disease-modifying therapy to reduce HF hospitalisation and CV death?

Accepted Answer

Add an SGLT2 inhibitor

Answer

Ivabradine

Answer

Hydralazine alone

Answer

Chronic digoxin

Answer

Loop diuretic daily regardless of symptoms

us-abfm MCQ (SBA): Heart Failure (HFrEF)

A 70-year-old with HFrEF (EF 30%), NYHA II, is on ACE inhibitor, beta blocker, and MRA. eGFR 65 mL/min/1.73m², K+ 4.8. Next disease-modifying therapy to reduce HF hospitalisation and CV death?